Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

March 23, 2023

Primary Completion Date

July 2, 2026

Study Completion Date

July 2, 2028

Conditions
Glioblastoma
Interventions
RADIATION

Accelerated Hypofractionated Radiation Therapy

Undergo short course RT

PROCEDURE

Computed Tomography

Undergo CT simulation

DRUG

Fluorodopa F 18

Given IV

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Positron Emission Tomography

Undergo PET

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Complete questionnaires

RADIATION

Radiation Therapy

Undergo standard course RT

DRUG

Temozolomide

Given PO

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

Trial Locations (8)

54601

Mayo Clinic Health System-Franciscan Healthcare, La Crosse

54701

Mayo Clinic Health System-Eau Claire, Eau Claire

55057

Mayo Clinic Radiation Therapy - Northfield, Northfield

55905

Mayo Clinic in Rochester, Rochester

56001

Mayo Clinic Health Systems-Mankato, Mankato

56007

Mayo Clinic Health System in Albert Lea, Albert Lea

85259

Mayo Clinic in Arizona, Scottsdale

32224-9980

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05781321 - Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study | Biotech Hunter | Biotech Hunter